-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

903.O2.6 903. Health Services Research—Malignant Conditions (Myeloid Disease): Treatment and Publication Patterns in Myeloid Malignancies

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, AML, CML, Diseases, Non-Biological, Elderly, Therapies, Combinations, chemotherapy, Study Population, Lymphoid Malignancies, Clinically relevant, Myeloid Malignancies, Quality Improvement
Monday, December 7, 2020: 9:00 AM-10:30 AM
Anita J Kumar, MD, MS, Tufts Medical Center, Tufts Medical Center and Sarah A Wall, MD, The Ohio State University
No relevant conflicts of interest to declare.
9:00 AM

Rong Wang, PhD1*, Rory M. Shallis, MD2, Jan Philipp Bewersdorf, MD3*, Amer M. Zeidan, MBBS, MHS4, Scott F. Huntington, MD, MPH5, Xiaomei Ma, PhD6* and Nikolai A. Podoltsev, MD, PhD7

1Yale University School of Public Health, New Haven, CT
2Yale Cancer Center, West Haven, CT
3Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
4Yale University School of Medicine and Yale Cancer Center, New Haven, CT
5Hematology, Yale University School of Medicine, New Haven, CT
6Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT
7Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Madison, CT

9:15 AM

Esther Natalie Oliva, MD1, Suman Kambhampati, MD2,3*, Albert Oriol4*, Ignazia La Torre5*, Barry Skikne, MD6,7*, C.L. Beach, PharmD7*, Keshava Kumar, PhD7*, Qian Dong, DrPH7*, Clara Chen7*, Sandip Ranjan, MTech8*, Zephirin Kiendrebeogo, Msc, PMP9* and Thorsten Braun, MD, PhD10

1Division of Hematology, Azienda Ospedaliena (B-M-M), Bologna, Italy
2VA Medical Center, Kansas City, MO
3Sarah Cannon at Research Medical Center, Kansas City, MO
4Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
5Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
6Kansas University Medical Center, Kansas City, KS
7Bristol Myers Squibb, Princeton, NJ
8SmartAnalyst India Pvt. Ltd, Gurgaon, India
9SmartAnalyst, Inc., New York, NY
10Hopital Avicenne, AP-HP, Paris XIII University, Bobigny, France

9:30 AM

Vanessa E Kennedy, MD1, Theresa Keegan, PhD, MS2, Qian Li, MS3*, Fran Maguire, PhD, MPH4* and Lori Muffly, MD, MS5

1University of California- San Francisco, San Francisco, CA
2University of California, Davis, Sacramento, CA
3Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
4California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Health, Institute for Population Health Improvement, Davis, CA
5Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA

9:45 AM

Ankita Kapoor, MD1, Mehul P. Patel, MD2, Arjun Khunger, MD3*, Mazen Jizzini, MD4*, Mohammad Ammad Ud Din, MD1*, Simrat Gill, MD1*, Samar Nasir, MD4*, Dharmini Manogna, MD1, Roopali Goyal Gandhi, MD1*, Nikhil Agrawal, MD5*, Syed Ather Hussain, MD1*, Pulkit Gandhi, MD6* and Saad Jamshed, MD2

1Division of Internal Medicine, Rochester General Hospital, Rochester, NY
2Lipson Cancer Institute, Rochester General Hospital, Rochester, NY
3Division of Internal Medicine, Memorial Hospital West, Pembroke Pines, FL
4Division of Internal Medicine, University at Buffalo, Buffalo, NY
5Division of Cardiovascular Diseases, University of Texas at Houston/MD Anderson Cancer Center, Houston, TX
6Rochester General Hospital, Rochester, NY

10:00 AM

Gabriel Tremblay, DBA, MSc, BS1*, Patrick Daniele1*, Mike Dolph, MSc BHSc1*, Timothy J. Bell2*, Geoffrey Chan, MD3, Andrew Brown, PhD2* and Joseph C Cappelleri, PhD, MPH, MS2*

1Purple Squirrel Economics, Montreal, QC, Canada
2Pfizer Inc., New York, NY
3Pfizer Inc, Collegeville, PA

10:15 AM

Peter Paschka, MD1, Hervé Dombret, MD2*, Xavier Thomas, MD, PhD3, Christian Recher, MD, PhD4, Sylvain Chantepie, MD5*, Pau Montesinos Fernandez, MD, PhD6,7*, Evelyn Acuña-Cruz, MD6*, Paresh Vyas, MRCP, FRCP, FRCPath8, Karl-Anton Kreuzer, MD9*, Michael Heuser10, Klaus H. Metzeler, MD11, Michael Dennis, MD12, Bruno Quesnel, MD, PhD13*, Hunault-Berger Mathilde, MD, PhD14*, Mohamad Mohty, MD, PhD15, Arnaud Pigneux, MD, PhD16*, Stephane De Botton, MD, PhD17*, Daniela Weber, MSc18*, Konstanze Dohner, MD1, Gary Milkovich, PharmD19*, John Reitan, PharmD19*, Sarah C MacDonald, SD20*, Deborah Casso, MPH21*, Michael Storm, MSc22*, Hua Liu, PhD22*, Stephanie M. Kapsalis, BS22*, Eyal C. Attar, MD22*, Thomas Winkler, MD23* and Hartmut Döhner, MD1*

1Universitätsklinikum Ulm, Ulm, Germany
2Hôpital Saint-Louis, Paris, France
3Centre Hospitalier Universitaire de Lyon-Sud, Lyon, France
4Institut Universitaire du Cancer de Toulouse Oncopole, CHU de Toulouse, Toulouse, France
5Institut d’Hématologie de Basse-Normandie, Centre Hospitalier Universitaire de Caen, Caen, France
6Hospital Universitari i Politècnic La Fe, Valencia, Spain
7CIBERONC, Instituto Carlos III, Madrid, Spain
8University of Oxford, Oxford, United Kingdom
9Uniklinik Köln, Köln, Germany
10Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
11Department of Hematology and Oncology, University of Munich, Munich, Germany
12The Christie NHS Foundation Trust, Manchester, United Kingdom
13Centre Hospitalier Régional Universitaire de Lille, Lille, France
14CRCINA Centre Hospitalier Universitaire d'Angers, Angers, France
15Saint Antoine Hospital, Paris, France
16Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
17Institut Gustave Roussy, Villejuif, France
18Klinik für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany
19RJM Group, LLC, Washington, DC
20IQVIA, Kirkland, QC, Canada
21IQVIA, Seattle, WA
22Agios Pharmaceuticals, Inc, Cambridge, MA
23Agios Pharmaceuticals, Inc., Cambridge, MA

*signifies non-member of ASH